Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy. (Q39085623)
Jump to navigation
Jump to search
scientific article published on 4 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy. |
scientific article published on 4 October 2013 |
Statements
Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy (English)
Gail D Lewis Phillips
Carter T Fields
Guangmin Li
Donald Dowbenko
Gabriele Schaefer
Howard A Burris
Kathy S Albain
Nadia Harbeck
Veronique Dieras
Diana Crivellari
Liang Fang
Ellie Guardino
Steven R Olsen
Lisa M Crocker
Mark X Sliwkowski
4 October 2013
1 reference